CHASSIDY WEATHERFORD: Open Payments
NPI 1013676949 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 9 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Octapharma USA, Inc. | 1 | $25 |
| Geron Corporation | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Coherus Oncology, Inc. | 1 | $21 |
| Kite Pharma, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: OCTAGAM IMMUNE GLOBULIN (HUMAN), RYTELO, Padcev, LOQTORZI, Yescarta, OJJAARA, NERLYNX, Lenvima.
Industry payments across KY — which companies pay providers there.
